{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:04:17Z","timestamp":1787342657377,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"am","delay-in-days":280,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000040","name":"American Parkinson's Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016948","name":"Tau Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG006786"],"award-info":[{"award-number":["AG006786"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG011378"],"award-info":[{"award-number":["AG011378"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG034676"],"award-info":[{"award-number":["AG034676"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG041851"],"award-info":[{"award-number":["AG041851"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG054449"],"award-info":[{"award-number":["AG054449"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1 AG069052-01A"],"award-info":[{"award-number":["RF1 AG069052-01A"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG016574"],"award-info":[{"award-number":["AG016574"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["NS097495"],"award-info":[{"award-number":["NS097495"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015595","name":"GHR Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016608","name":"Rainwater Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.neurobiolaging.2022.07.006","type":"journal-article","created":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T01:15:59Z","timestamp":1658625359000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2770-0691","authenticated-orcid":false,"given":"Jonathan","family":"Graff-Radford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina I.","family":"Hofrenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Lesnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Moloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Rabinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janisse N.","family":"Cabrera-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M.","family":"Rothberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Przybelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Algeciras-Schimnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aivi T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthi","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0001","series-title":"Association AP. Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2022.07.006_bib0002","article-title":"Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration","volume":"7","author":"Ashton","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0003","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0004","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0005","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1038\/s41467-021-23746-0","article-title":"Plasma biomarkers of Alzheimer\u2019s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations","volume":"12","author":"Cullen","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0006","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13195-020-00728-w","article-title":"Comparison of ELISA- and SIMOA-based quantification of plasma A\u03b2 ratios for early detection of cerebral amyloidosis","volume":"12","author":"De Meyer","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0007","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12883-017-0945-8","article-title":"Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke","volume":"17","author":"De Vos","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0008","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1212\/WNL.0b013e31824e8e7f","article-title":"Staging and natural history of cerebrovascular pathology in dementia","volume":"78","author":"Deramecourt","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0009","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5853\/jos.2017.02565","article-title":"Serum neurofilament light chain levels are related to small vessel disease burden","volume":"20","author":"Duering","year":"2018","journal-title":"J Stroke"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0010","first-page":"12","article-title":"Plasma neurofilament light predicts mortality in patients with stroke","author":"Gendron","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0011","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1212\/WNL.0000000000012513","article-title":"Associations of fully automated CSF and novel plasma biomarkers with alzheimer disease neuropathology at autopsy","volume":"97","author":"Grothe","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0013","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1212\/WNL.0000000000011226","article-title":"Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer disease","volume":"96","author":"Ill\u00e1n-Gala","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0014","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1038\/srep26801","article-title":"Plasma \u03b2-amyloid in Alzheimer\u2019s disease and vascular disease","volume":"6","author":"Janelidze","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2018.3459","article-title":"Association of cerebrospinal fluid neurofilament light protein with risk of mild cognitive impairment among individuals without cognitive impairment","volume":"76","author":"Kern","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0016","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13195-021-00944-y","article-title":"Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes","volume":"13","author":"Marks","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0017","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0018","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0019","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jamaneurol.2017.1359","article-title":"Association of plasma total tau level with cognitive decline and risk of mild cognitive impairment or dementia in the mayo clinic study on aging","volume":"74","author":"Mielke","year":"2017","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0020","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1212\/WNL.0000000000007767","article-title":"Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures","volume":"93","author":"Mielke","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0021","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National institute on aging-alzheimer\u2019s association guidelines for the neuropathologic assessment of alzheimer\u2019s disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0023","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0024","doi-asserted-by":"crossref","first-page":"e12242","DOI":"10.1002\/dad2.12242","article-title":"The global Alzheimer\u2019s Association round robin study on plasma amyloid \u03b2 methods","volume":"13","author":"Pannee","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0026","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0027","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0028","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-022-02408-5","article-title":"Plasma biomarkers for Alzheimer\u2019s disease in relation to neuropathology and cognitive change","volume":"143","author":"Smirnov","year":"2022","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0029","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.neurobiolaging.2008.09.011","article-title":"Contribution of vascular pathology to the clinical expression of dementia","volume":"31","author":"Strozyk","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0030","article-title":"Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities","author":"Syrjanen","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0031","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0032","doi-asserted-by":"crossref","first-page":"e1338","DOI":"10.1212\/WNL.0000000000006282","article-title":"Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke","volume":"91","author":"Tiedt","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.07.006_bib0033","article-title":"Examining the association between blood-based biomarkers and human post mortem neuropathology in the University of Kentucky Alzheimer\u2019s disease research center autopsy cohort","author":"Winder","year":"2022","journal-title":"Alzheimers Dement"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022001610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022001610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:41:54Z","timestamp":1759318914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458022001610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":33,"alternative-id":["S0197458022001610"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.07.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}